We are live on ! Find out more
AMBI

Ambit Biosciences Corp
AMBI

Delisted

AMBI was delisted on the 10th of November, 2014.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$10.4M +$10.7M +1,490,769 New
JRJ
2
Jeffrey R. Jay
$7M +$7.15M +1,000,000 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.62M +$5.74M +802,250 New
BBA
4
Baker Bros. Advisors
New York
$5.24M +$5.35M +747,962 New
WC
5
Wexford Capital
Florida
$4.36M +$4.45M +622,500 New
JP Morgan Chase
6
JP Morgan Chase
New York
$1.53M +$1.56M +218,300 New
PRCM
7
Pine River Capital Management
Minnesota
$1.22M +$1.24M +174,100 New
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$525K +$536K +74,989 New
FM
9
Forward Management
California
$408K +$408K +57,000 New
Goldman Sachs
10
Goldman Sachs
New York
$184K +$188K +26,297 New
Morgan Stanley
11
Morgan Stanley
New York
$174K +$178K +24,834 New
SIP
12
Stoneridge Investment Partners
Pennsylvania
$153K +$157K +21,906 New
TRCT
13
Tower Research Capital (TRC)
New York
$29K +$29.6K +4,144 New
Citigroup
14
Citigroup
New York
$1K +$1.07K +150 New
TCM
15
Tang Capital Management
California
+$329 +46 New